COM:C4THERAPEUTICS
C4 Therapeutics
- Stock
Last Close
4.01
22/11 21:00
Market Cap
344.03M
Beta: -
Volume Today
1.36M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -15.71M - | -34.10M 117.04% | -66.33M 94.54% | -83.89M 26.47% | -128.18M 52.79% | -132.49M 3.37% | |
depreciation and amortization | 1.27M - | 1.59M 25.29% | 1.62M 1.38% | 1.49M 7.73% | 1.68M 12.33% | 7.74M 361.63% | |
deferred income tax | 66K - | 350K 430.30% | 5.58M 1,494.57% | 1.88M 66.33% | 10.05M - | ||
stock based compensation | 582K - | 1.64M 182.13% | 3.43M 109.01% | 21.51M 526.81% | 30.02M 39.53% | 27.23M 9.27% | |
change in working capital | -5.56M - | 84.98M 1,628.73% | -13.18M 115.51% | -30.09M 128.35% | -16.78M 44.24% | -6.94M 58.65% | |
accounts receivables | -84.94M - | 81.81M 196.32% | 139K 99.83% | -1.23M 986.33% | 4.24M 444.48% | -10.33M 343.33% | |
inventory | -2.22M - | 2.17M 197.70% | -1.58M 172.78% | -2.63M 66.27% | |||
accounts payables | 578K - | 4.23M 632.01% | 467K 88.96% | -1.18M 352.46% | -3.33M 182.70% | 273K 108.19% | |
other working capital | 81.03M - | -3.23M 103.99% | -12.20M 277.22% | -25.05M 105.29% | -17.69M 29.39% | 3.12M 117.61% | |
other non cash items | 2.37M - | 1.14M 51.69% | 1.63M 42.74% | 2.13M 30.68% | 7.32M 243.16% | -12.43M 269.78% | |
net cash provided by operating activities | -16.98M - | 55.61M 427.51% | -67.25M 220.92% | -86.97M 29.32% | -105.94M 21.82% | -106.84M 0.85% | |
investments in property plant and equipment | -2.69M - | -1.35M 49.83% | -650K 51.82% | -1.28M 96.46% | -5.50M 330.38% | -1.71M 68.92% | |
acquisitions net | 63K - | 189.85M 301,257.14% | 188.06M 0.95% | -63.92M 133.99% | |||
purchases of investments | -4.99M - | -79M 1,483.17% | -293.86M 271.97% | -537.74M 83.00% | -219.53M 59.18% | -129.90M 40.83% | |
sales maturities of investments | 44.60M - | 78.67M 76.38% | 104M 32.20% | 349.68M 236.23% | 283.44M 18.94% | 289.95M 2.30% | |
other investing activites | -189.85M - | -188.06M 0.95% | 63.92M 133.99% | ||||
net cash used for investing activites | 36.92M - | -1.62M 104.39% | -190.50M 11,659.57% | -189.34M 0.61% | 58.42M 130.86% | 158.35M 171.04% | |
debt repayment | -11.97M - | -12.50M - | |||||
common stock issued | 47K - | 274K 482.98% | 340.60M 124,206.20% | 169.47M 50.25% | 777K 99.54% | 57.73M 7,329.99% | |
common stock repurchased | -30K - | -194K 546.67% | -110K - | ||||
dividends paid | -11.97M - | ||||||
other financing activites | 1.91M - | -30K 101.57% | 32.47M 108,343.33% | 1.94M 94.04% | 370K 80.88% | 368K 0.54% | |
net cash used provided by financing activities | 1.96M - | 244K 87.56% | 348.93M 142,904.92% | 171.40M 50.88% | 1.15M 99.33% | 45.49M 3,865.91% | |
effect of forex changes on cash | -164K - | ||||||
net change in cash | 21.90M - | 54.24M 147.65% | 91.18M 68.11% | -104.90M 215.05% | -46.37M 55.80% | 96.84M 308.83% | |
cash at beginning of period | 16.99M - | 38.89M 128.93% | 93.13M 139.47% | 184.30M 97.91% | 79.40M 56.92% | 29.75M 62.53% | |
cash at end of period | 38.89M - | 93.13M 139.47% | 184.30M 97.91% | 79.40M 56.92% | 33.03M 58.40% | 126.59M 283.22% | |
operating cash flow | -16.98M - | 55.61M 427.51% | -67.25M 220.92% | -86.97M 29.32% | -105.94M 21.82% | -106.84M 0.85% | |
capital expenditure | -2.69M - | -1.35M 49.83% | -650K 51.82% | -1.28M 96.46% | -5.50M 330.38% | -1.71M 68.92% | |
free cash flow | -19.67M - | 54.27M 375.88% | -67.90M 225.12% | -88.24M 29.96% | -111.44M 26.28% | -108.55M 2.59% |
All numbers in USD (except ratios and percentages)